MYC and neuroblastoma: Integration of both scATAC- and scRNA-seq data for the genes associated with affected pathways in myeloid cells in NB patients compared to controls (Fig. 4c) revealed that loss of gene expression for MYC and E2F targets was associated with predominately closed chromatin.